Cronos (CRON) Non-Current Debt (2017 - 2023)
Cronos' (CRON) quarterly Non-Current Debt came in at $1.4 million in Q1 2023, down 27.44% year-on-year from $1.9 million in Q1 2022, and down 0.94% quarter-over-quarter from $1.4 million in Q4 2022.
Cronos (CRON) Non-Current Debt (2017 - 2023) Analysis & Trends
Cronos' Non-Current Debt history runs 7 years deep, the most recent figure standing at $1.4 million for Q1 2023.
- On a quarterly basis, Non-Current Debt fell 27.44% year-over-year to $1.4 million in Q1 2023; TTM through Mar 2023 was $1.4 million, a 27.44% decrease from a year earlier, with the FY2022 full-year figure at $1.4 million, down 27.71% from the prior year.
- Non-Current Debt retreated to $1.4 million in Q1 2023 per CRON's latest filing, from $1.4 million in the prior quarter.
- Across five years, Non-Current Debt topped out at $3.0 million in Q2 2020 and bottomed at $1.3 million in Q3 2022.
- The 5-year median for Non-Current Debt is $1.8 million (2019), against an average of $1.9 million.
- Biggest YoY gain for Non-Current Debt was 26.65% in 2021; the steepest drop was 41.99% in 2021.
- Year by year, Non-Current Debt stood at $1.8 million in 2019, then advanced by 18.66% to $2.2 million in 2020, then decreased by 12.57% to $1.9 million in 2021, then decreased by 27.71% to $1.4 million in 2022, then dropped by 0.94% to $1.4 million in 2023.
- Per Business Quant, the three latest CRON Non-Current Debt figures stand at $1.4 million (Q1 2023), $1.4 million (Q4 2022), and $1.3 million (Q3 2022).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 10.34 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 14.02 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 27.86 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 12.41 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 3.74 Bn |
| 10 | Cronos | 1.04 Bn | 267.78 Mn | 19.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 1.37 Mn |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.35 Mn |
| Jun 30, 2022 | 1.36 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 1.91 Mn |
| Sep 30, 2021 | 1.83 Mn |
| Jun 30, 2021 | 1.77 Mn |
| Mar 31, 2021 | 2.13 Mn |
| Dec 31, 2020 | 2.19 Mn |
| Sep 30, 2020 | 2.89 Mn |
| Jun 30, 2020 | 3.05 Mn |
| Mar 31, 2020 | 1.68 Mn |
| Dec 31, 2019 | 1.84 Mn |
| Dec 31, 2018 | 1.57 Mn |
| Dec 31, 2017 | 4.22 Mn |